1. Home
  2. IBIO vs HAIN Comparison

IBIO vs HAIN Comparison

Compare IBIO & HAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$0.76

Market Cap

56.0M

Sector

Health Care

ML Signal

HOLD

Logo Hain Celestial Group Inc. (The)

HAIN

Hain Celestial Group Inc. (The)

HOLD

Current Price

$0.24

Market Cap

53.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBIO
HAIN
Founded
2008
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
56.0M
53.7M
IPO Year
2009
1996

Fundamental Metrics

Financial Performance
Metric
IBIO
HAIN
Price
$0.76
$0.24
Analyst Decision
Strong Buy
Hold
Analyst Count
9
3
Target Price
★ $5.69
$1.50
AVG Volume (30 Days)
858.9K
★ 1.2M
Earning Date
11-11-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.71
42.95
EPS
★ N/A
N/A
Revenue
N/A
★ $2,457,769,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.58
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.73
$0.24
52 Week High
$3.82
$1.64

Technical Indicators

Market Signals
Indicator
IBIO
HAIN
Relative Strength Index (RSI) 19.34 23.98
Support Level N/A N/A
Resistance Level $1.52 $0.64
Average True Range (ATR) 0.08 0.06
MACD -0.03 -0.02
Stochastic Oscillator 6.77 9.04

Price Performance

Historical Comparison
IBIO
HAIN

About IBIO iBio Inc.

iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

Share on Social Networks: